Bottom line
How much do SHSSX and LYFIX overlap?
18% of their top holdings overlap by weight. 6 securities appear in both funds' top 25, making up 16.7% of SHSSX's assets and 20.0% of LYFIX's. They are substantially different portfolios, so owning both adds real diversification.
SHSSX holds far more positions (155 vs 62), so it is broader beyond the top names.
Updated Nov 22, 2026
Overlap at a glance
Holdings SHSSX and LYFIX have in common
| Holding | % of SHSSX | % of LYFIX | Overlap |
|---|---|---|---|
| Gilead Sciences Inc GILD | 4.19% | 5.53% | 4.19% |
| Abbvie Inc ABBV | 3.94% | 1.95% | 1.95% |
| Amgen Inc AMGN | 3.37% | 1.83% | 1.83% |
| Vertex Pharmaceuticals Inc VRTX | 2.74% | 5.33% | 2.74% |
| Argenx Se ARGX | 1.26% | 3.59% | 1.26% |
| Biogen Inc BIIB | 1.21% | 1.80% | 1.21% |
Source: SEC Form N-PORT (periods May 29, 2026 / Jun 30, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in SHSSX
- Eli Lilly & Company — 12.29%
- Johnson & Johnson — 8.77%
- Unitedhealth Group Inc — 6.10%
- Merck & Company Inc — 4.94%
- Thermo Fisher Scientific Inc — 3.02%
- Pfizer Inc — 2.61%
- Edwards Lifesciences Corp — 2.51%
- Danaher Corp — 2.00%
- Abbott Laboratories — 1.97%
- Intuitive Surgical Inc — 1.95%
- Teva Pharmaceutical Industries Ltd — 1.87%
- Boston Scientific Corp — 1.59%
- Elevance Health Inc — 1.56%
- Astrazeneca Plc — 1.21%
- Stryker Corp — 1.15%
Only in LYFIX
- Astrazeneca Plc — 4.63%
- First American Funds Inc — 4.26%
- Roivant Sciences Ltd — 3.67%
- Neurocrine Biosciences Inc — 3.51%
- Incyte Corp — 3.51%
- Axsome Therapeutics Inc — 3.43%
- Apogee Therapeutics Inc — 3.28%
- Ionis Pharmaceuticals Inc — 2.62%
- Ascendis Pharma A/s — 2.62%
- Insmed Inc — 2.60%
- Protagonist Therapeutics Inc — 2.41%
- Personalis Inc — 2.27%
- Rhythm Pharmaceuticals Inc — 2.25%
- Jazz Pharmaceuticals Plc — 1.87%
- Catalyst Pharmaceuticals Inc — 1.59%
Asset mix
| Asset type | SHSSX | LYFIX |
|---|---|---|
| Stocks | 99.8% | 95.8% |
| Cash & short-term funds | 1.4% | 4.3% |
Source: SEC Form N-PORT (periods May 29, 2026 / Jun 30, 2026)
Country mix
| Country | SHSSX | LYFIX |
|---|---|---|
| US | 93.9% | 76.0% |
| NL | 1.3% | 4.7% |
| GB | 1.4% | 4.6% |
| BM | 0.3% | 3.7% |
| FR | — | 2.8% |
| DK | — | 2.6% |
| IE | — | 2.4% |
| IL | 1.9% | — |
Source: SEC Form N-PORT (periods May 29, 2026 / Jun 30, 2026)
Check another pair
FAQ
How much do SHSSX and LYFIX overlap?
What stocks do SHSSX and LYFIX have in common?
Should I own both SHSSX and LYFIX?
Which holds more stocks, SHSSX or LYFIX?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.